Vijil Chenthamarakshan
Overview
Explore the profile of Vijil Chenthamarakshan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Notin P, Huang Y, Lozano A, Chenthamarakshan V, Marks D, et al.
ArXiv
. 2024 Dec;
PMID: 39679271
Designing novel functional proteins crucially depends on accurately modeling their fitness landscape. Given the limited availability of functional annotations from wet-lab experiments, previous methods have primarily relied on self-supervised models...
2.
Litsa E, Chenthamarakshan V, Das P, Kavraki L
Commun Chem
. 2023 Jun;
6(1):132.
PMID: 37353554
Elucidating the structure of a chemical compound is a fundamental task in chemistry with applications in multiple domains including drug discovery, precision medicine, and biomarker discovery. The common practice for...
3.
Chenthamarakshan V, Hoffman S, Owen C, Lukacik P, Strain-Damerell C, Fearon D, et al.
Sci Adv
. 2023 Jun;
9(25):eadg7865.
PMID: 37343087
Inhibitor discovery for emerging drug-target proteins is challenging, especially when target structure or active molecules are unknown. Here, we experimentally validate the broad utility of a deep generative framework trained...
4.
Scantlebury J, Vost L, Carbery A, Hadfield T, Turnbull O, Brown N, et al.
J Chem Inf Model
. 2023 May;
63(10):2960-2974.
PMID: 37166179
Over the past few years, many machine learning-based scoring functions for predicting the binding of small molecules to proteins have been developed. Their objective is to approximate the distribution which...
5.
Sharma B, Chenthamarakshan V, Dhurandhar A, Pereira S, Hendler J, Dordick J, et al.
Sci Rep
. 2023 Mar;
13(1):4908.
PMID: 36966203
Explainable machine learning for molecular toxicity prediction is a promising approach for efficient drug development and chemical safety. A predictive ML model of toxicity can reduce experimental cost and time...
6.
Cao Y, Das P, Chenthamarakshan V, Chen P, Melnyk I, Shen Y
Proc Mach Learn Res
. 2021 Aug;
139:1261-1271.
PMID: 34423306
Designing novel protein sequences for a desired 3D topological fold is a fundamental yet nontrivial task in protein engineering. Challenges exist due to the complex sequence-fold relationship, as well as...
7.
Das P, Sercu T, Wadhawan K, Padhi I, Gehrmann S, Cipcigan F, et al.
Nat Biomed Eng
. 2021 Jun;
5(8):942.
PMID: 34183803
No abstract available.
8.
Das P, Sercu T, Wadhawan K, Padhi I, Gehrmann S, Cipcigan F, et al.
Nat Biomed Eng
. 2021 Mar;
5(6):613-623.
PMID: 33707779
The de novo design of antimicrobial therapeutics involves the exploration of a vast chemical repertoire to find compounds with broad-spectrum potency and low toxicity. Here, we report an efficient computational...